Fiverr International Ltd vs Smith & Nephew plc — how do they compare? Fiverr International Ltd trades at $8.76 (market cap $314.57M), while Smith & Nephew plc trades at $29.95 (market cap $12.54B). The key difference: Smith & Nephew plc is far larger — about 39.9× Fiverr International Ltd's market cap, and Smith & Nephew plc pays a 2.65% dividend while Fiverr International Ltd pays none. Which is the better fit depends on your goals.
| FVRR | SNN | |
|---|---|---|
Market Cap | $314.57M | $12.54B |
Sector | Industrials | Health |
52-Week High | $26.67 | $38.70 |
52-Week Low | $8.75 | $28.73 |
Enterprise Value | $66.95M | $15.57B |
Dividend Yield | — | 2.65% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Smith & Nephew (SNN) trades at $30.08, down 0.1% with bearish technical signals. The company reported mixed Q2 2026 results with revenue growth below expectations, leading to a reduced full-year outlook. Fundamentals show strong profitability with 10.1% net margin and improving cash flow trends, though recent earnings misses have tempered sentiment.
Outlook remains cautious with analyst consensus at Hold (65% of coverage). Near-term risks include U.S. orthopedics weakness and competitive pressures, offset by robotics innovation and value-based care expansion. The stock offers stable fundamentals but faces execution challenges in key markets.
Trailing returns across standard periods
Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.
Read more on FVRR →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →